short-right-arrow logoMobile media-pie 1 7 % share download email linkedin round-download

Privacy Preference Centre

Your Privacy

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. We use two types of cookies on our website: cookies which are necessary for this website to function and analytics cookies. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Cookies used

  • CookieNotice
  • CookieAnalytics


Analytics Cookies

These are Google Analytics cookies which allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site and social media platforms All information these cookies collect is aggregated and therefore anonymous. This cookie is defaulted to ‘Active’, which means we will be able to track, on any anonymous basis, how many visitors we have to our site, and monitor its performance. If you wish to turn them off you can do so by unticking ‘Active’ and clicking ‘Save and Accept Cookies’. For more information on how these cookies work, including a link through to the Google Privacy Policy which sets out further information about data which Google may collect in the course of providing us with Analytics.

Cookies used

  • _ga

Targeting Cookies

We use necessary cookies to make our site work. We also use analytics cookies which collect information about how visitors use our website and help us to improve it; these are defaulted to ‘Active’, if you wish to turn them off you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and our Cookies Policy.

Our response to Coronavirus

Bridgepoint is proactively supporting its people, its portfolio companies and their employees during these extraordinarily difficult and challenging times.

Find Out More

Bridgepoint in the News

14 July 2014

Bridgepoint Development Capital acquires Phlexglobal

Phlexglobal, the specialist provider of technology-enabled document management solutions and other support services to the global clinical research market, has been acquired by Bridgepoint Development Capital (‘BDC’) from Inflexion in a transaction totalling £42 million.

Established in 1997, Phlexglobal has offices in Amersham, UK and Philadelphia, US and employs 230 people. The company supports administrative and operational aspects of the pharmaceutical clinical trial process. It is a specialist in Trial Master File ('TMF') software and services to global pharmaceutical and biotech sponsors and clinical research organisations.

A TMF is a collection of all the essential documents created during a clinical trial. Required by law, the TMF demonstrates compliance with regulatory standards for the conduct of a clinical trial. TMFs are central to the inspection regime that oversees the conduct of clinical trials. Phlexglobal offers an end to end solution to cater for all TMF requirements, from fully outsourced technology enabled solutions (known as 'eTMFs') to a range of ancillary project related services.

The number of active pharma R&D projects worldwide has been increasing at c.2% p.a., this growth together with increasing trial complexity has led to a rapid increase in the number of TMF documents being created. These drivers have grown the total addressable TMF market to be worth an estimated £700 million annually. The market is forecast to continue to grow at 5% p.a. over the next five years with an increasing proportion of the market being outsourced.

Alan Payne, partner at Bridgepoint Development Capital, said: "Phlexglobal has delivered consistent revenue and profit growth. With the increasing emergence of technology in the TMF market, the company is now well placed to replicate its eminence in the services market to become the eTMF provider of choice and the leading TMF services brand."

Steven Kent, chairman of Phlexglobal, said: "The outsourced pharmaceutical industry is experiencing strong growth on the back of increased R&D spend and more complex regulation. The Phlexglobal management team have already developed a close working relationship with BDC. We share a strong vision of how we can grow the business rapidly over the next few years by further enhancing our technology and services and extending our geographic reach to new customers."

For the year to December 2013, Phlexglobal reported revenue and EBITDA of £15.3 million and £4.5 million respectively.

Senior debt and working capital facilities to support the transaction were provided by Lloyds Bank Commercial Banking.

Advisers involved in this transaction included:

For BDC - Travers Smith (legal), DC Advisory (corporate finance), E&Y (financial due diligence)

For vendor - BDO (corporate finance), Gateley (legal).

Close

Contact us

If you are interested in working for Bridgepoint, please complete the form below.

Close

Investor reports registration

To access investor reports through the web based reporting facility, please fill in the form to register for an account.

The information submitted on this form will be used for the sole purpose of registering you as an account user and will not be shared with third parties.

Close

Request a copy of The Point

Mandatory fields are marked as (required*)